Pneumococcal conjugate second or third-dose vaccines (PCVc) in Cameroon
Cameroon: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 82.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Cameroon, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Cameroon is 82.0%, measured in 2025.
That represents a change of up 7.9% on the previous year and up 6.5% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Cameroon peaked at 84.0% in 2012 and was at its lowest, 0.0%, in 2008.
Cameroon ranks 106th of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Cameroon, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 23.0% | — |
| 2012 | 84.0% | +265.2% |
| 2013 | 75.0% | -10.7% |
| 2014 | 77.0% | +2.7% |
| 2015 | 77.0% | +0.0% |
| 2016 | 78.0% | +1.3% |
| 2017 | 73.0% | -6.4% |
| 2018 | 68.0% | -6.8% |
| 2019 | 67.0% | -1.5% |
| 2020 | 69.0% | +3.0% |
| 2021 | 70.0% | +1.4% |
| 2022 | 70.0% | +0.0% |
| 2023 | 75.0% | +7.1% |
| 2024 | 76.0% | +1.3% |
| 2025 | 82.0% | +7.9% |
Cameroon compared with similar countries
- Cameroon's 82.0% is below the median for lower middle income countries, which is 84.0%, 98% of the median. (47 countries reporting)
- Cameroon's 82.0% is below the median for Sub-Saharan Africa, which is 82.5%, 99% of the median. (48 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Cameroon changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +265.2% | 23.0% | 84.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 62.2% | 0.0% | 84.0% | 10 |
| 2020s | 73.7% | 69.0% | 82.0% | 6 |
Countries ranked near Cameroon
More health data for Cameroon
- Un projection of annual infant deaths, annual growth rate -1.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7821 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 786.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12,841 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 17 (2025)
- Population ages 00-04, female, annual growth rate 1.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0746 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.21 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Cameroon?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Cameroon was 82.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Cameroon?
- The highest recorded value was 84.0% in 2012.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Cameroon?
- The lowest recorded value was 0.0% in 2008.
- How does Cameroon rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cameroon ranks 106th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Cameroon?
- Over the last ten years it is up 6.5%. The long-run trend across the full record is rising.
- Where does this Cameroon data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).